ATH — Alterity Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- AU$16.81m
- AU$4.75m
- AU$0.02m
Annual balance sheet for Alterity Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 14.4 | 9.2 | 28.1 | 34.8 | 15.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.83 | 0.061 | 4.28 | 4.73 | 8.67 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 19.9 | 9.84 | 33.5 | 41.1 | 27 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.049 | 0.071 | 0.097 | 0.219 | 0.269 |
| Total Assets | 19.9 | 9.91 | 33.6 | 41.4 | 27.3 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.32 | 2.71 | 3.07 | 5.82 | 4.38 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.36 | 2.76 | 3.12 | 5.89 | 4.5 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 16.6 | 7.15 | 30.5 | 35.5 | 22.8 |
| Total Liabilities & Shareholders' Equity | 19.9 | 9.91 | 33.6 | 41.4 | 27.3 |
| Total Common Shares Outstanding |